Talphera (TLPH) Net Income towards Common Stockholders (2010 - 2025)
Talphera (TLPH) recorded quarterly Net Income towards Common Stockholders of $73000.0 in Q1 2025, up 101.62% quarter-over-quarter from -$4.5 million in Q4 2023.
Talphera (TLPH) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Talphera's Net Income towards Common Stockholders history runs 15 years deep, the most recent figure standing at $73000.0 for Q1 2025.
- In Q1 2025, Net Income towards Common Stockholders changed N/A year-over-year to $73000.0; the TTM figure through Dec 2025 stood at $73000.0 (changed N/A YoY), while the FY2023 annual figure was -$18.4 million, down 134.26% from the prior year.
- Net Income towards Common Stockholders was $73000.0 for Q1 2025 at Talphera, up from -$4.5 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $66.8 million in Q2 2022 to a low of -$9.9 million in Q2 2021.
- Historically, Net Income towards Common Stockholders has averaged $469923.1 across 4 years, with a median of -$4.5 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders jumped 778.14% in 2022, then slumped 197.64% in 2023.
- A 4-year view of Net Income towards Common Stockholders shows it stood at -$7.9 million in 2021, then surged by 158.43% to $4.6 million in 2022, then plunged by 197.64% to -$4.5 million in 2023, then jumped by 101.62% to $73000.0 in 2025.
- The last three Net Income towards Common Stockholders figures came in at $73000.0 (Q1 2025), -$4.5 million (Q4 2023), and -$1.4 million (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 366.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 1.99 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2023 | -4.52 Mn |
| Sep 30, 2023 | -1.36 Mn |
| Jun 30, 2023 | -4.43 Mn |
| Mar 31, 2023 | -8.22 Mn |
| Dec 31, 2022 | 4.63 Mn |
| Sep 30, 2022 | -6.94 Mn |
| Jun 30, 2022 | 66.80 Mn |
| Mar 31, 2022 | -4.06 Mn |
| Dec 31, 2021 | -7.92 Mn |
| Sep 30, 2021 | -8.38 Mn |
| Jun 30, 2021 | -9.85 Mn |
| Mar 31, 2021 | -9.74 Mn |
| Dec 31, 2020 | -8.92 Mn |
| Sep 30, 2020 | -8.93 Mn |
| Jun 30, 2020 | -6.61 Mn |
| Mar 31, 2020 | -16.77 Mn |
| Dec 31, 2019 | -14.42 Mn |
| Sep 30, 2019 | -12.73 Mn |
| Jun 30, 2019 | -12.41 Mn |